1000 resultados para 74-525_Site
Resumo:
In 2005 the EU and Turkey officially started accession negotiations that were intended to lead to Turkey’s full membership of the EU. Yet today, the Turkish accession process has virtually ground to a halt and lost all credibility. Talk of alternatives to full membership can be heard from various sides; we highlight four instances of what we call ‘parallelism’, namely the elusive concept of a ‘privileged partnership’, the EU-Turkey customs union, the recently launched ‘Positive Agenda’ and Turkish participation in the Energy Community Treaty. While a privileged partnership represents a more comprehensive but still remote framework for EU-Turkish relations, the latter three are merely an escape route from preaccession. We conclude our analysis with a discussion on Turkey’s possible membership of the European Economic Area, which in effect would serve none of the parties involved. We conclude that both partners, the EU and Turkey, would be well advised to remember their pre-accession commitments of 13 years ago – for their mutual benefit.
Resumo:
OBJECTIVES: To determine the cost-effectiveness of influenza vaccination in people aged 65-74 years in the absence of co-morbidity. DESIGN: Primary research: randomised controlled trial. SETTING: Primary care. PARTICIPANTS: People without risk factors for influenza or contraindications to vaccination were identified from 20 general practitioner (GP) practices in Liverpool in September 1999 and invited to participate in the study. There were 5875/9727 (60.4%) people aged 65-74 years identified as potentially eligible and, of these, 729 (12%) were randomised. INTERVENTION: Participants were randomised to receive either influenza vaccine or placebo (ratio 3:1), with all individuals receiving pneumococcal vaccine unless administered in the previous 10 years. Of the 729 people randomised, 552 received vaccine and 177 received placebo; 726 individuals were administered pneumococcal vaccine. MAIN OUTCOME MEASURES AND METHODOLOGY OF ECONOMIC EVALUATION: GP attendance with influenza-like illness (ILI) or pneumonia (primary outcome measure); or any respiratory symptoms; hospitalisation with a respiratory illness; death; participant self-reported ILI; quality of life (QoL) measures at 2, 4 and 6 months post-study vaccination; adverse reactions 3 days after vaccination. A cost-effectiveness analysis was undertaken to identify the incremental cost associated with the avoidance of episodes of influenza in the vaccination population and an impact model was used to extrapolate the cost-effectiveness results obtained from the trial to assess their generalisability throughout the NHS. RESULTS: In England and Wales, weekly consultations for influenza and ILI remained at baseline levels (less than 50 per 100,000 population) until week 50/1999 and then increased rapidly, peaking during week 2/2000 with a rate of 231/100,000. This rate fell within the range of 'higher than expected seasonal activity' of 200-400/100,000. Rates then quickly declined, returning to baseline levels by week 5/2000. The predominant circulating strain during this period was influenza A (H3N2). Five (0.9%) people in the vaccine group were diagnosed by their GP with an ILI compared to two (1.1%) in the placebo group [relative risk (RR), 0.8; 95% confidence interval (CI) = 0.16 to 4.1]. No participants were diagnosed with pneumonia by their GP and there were no hospitalisations for respiratory illness in either group. Significantly fewer vaccinated individuals self-reported a single ILI (4.6% vs 8.9%, RR, 0.51; 95% CI for RR, 0.28 to 0.96). There was no significant difference in any of the QoL measurements over time between the two groups. Reported systemic side-effects showed no significant differences between groups. Local side-effects occurred with a significantly increased incidence in the vaccine group (11.3% vs 5.1%, p = 0.02). Each GP consultation avoided by vaccination was estimated from trial data to generate a net NHS cost of 174 pounds. CONCLUSIONS: No difference was seen between groups for the primary outcome measure, although the trial was underpowered to demonstrate a true difference. Vaccination had no significant effect on any of the QoL measures used, although vaccinated individuals were less likely to self-report ILI. The analysis did not suggest that influenza vaccination in healthy people aged 65-74 years would lead to lower NHS costs. Future research should look at ways to maximise vaccine uptake in people at greatest risk from influenza and also the level of vaccine protection afforded to people from different age and socio-economic populations.
Resumo:
The aim of this study was to determine the cost effectiveness of influenza vaccination for healthy people aged 65-74 years living in the UK. People without risk factors for influenza (chronic heart, lung or renal disease, diabetic, immuno-suppressed or those living in an institution) were identified from 20 general practitioner (GP) practices in Liverpool in September 1999. 729/5875 (12.4%) eligible individuals were recruited and randomised to receive either influenza vaccine or placebo (ratio 3: 1)! with all participants receiving 23-valent-pneumococcal polysaccharide vaccine unless already administered. The primary analysis was the frequency of influenza as recorded by a GP diagnosis of pneumonia or influenza like illness. In 2000, the UK vaccination policy was changed with influenza vaccine becoming available. for all people aged 65 years and over irrespective of risk. As a consequence of this policy change. the study had to be fundamentally restructured and only results obtained over a one rather than the originally planned two-year randomised controlled trial framework were used. Results from 1999/2000 demonstrated no significant difference between groups for the primary outcome (relative risk 0.8, 95%, CI 0.16-4.1). In addition. there were no deaths or hospitalisations for influenza associated respiratory illness in either group. The subsequent analysis. using both national and local sources of evidence, estimated the following cost effectiveness indicators: (1) incremental NHS cost per GP consultation avoided = pound2000; (2) incremental NHS cost per hospital admission avoided = pound61,000: (3) incremental NHS cost per death avoided = pound1.900.000 and (4) incremental NHS cost per QALY gained = pound304,000. The analysis suggested that influenza vaccination in this Population would not be cost effective. (C) 2004 Elsevier Ltd. All rights reserved.
Resumo:
The INSIG2 rs7566605 polymorphism was identified for obesity (BMI> or =30 kg/m(2)) in one of the first genome-wide association studies, but replications were inconsistent. We collected statistics from 34 studies (n = 74,345), including general population (GP) studies, population-based studies with subjects selected for conditions related to a better health status ('healthy population', HP), and obesity studies (OB). We tested five hypotheses to explore potential sources of heterogeneity. The meta-analysis of 27 studies on Caucasian adults (n = 66,213) combining the different study designs did not support overall association of the CC-genotype with obesity, yielding an odds ratio (OR) of 1.05 (p-value = 0.27). The I(2) measure of 41% (p-value = 0.015) indicated between-study heterogeneity. Restricting to GP studies resulted in a declined I(2) measure of 11% (p-value = 0.33) and an OR of 1.10 (p-value = 0.015). Regarding the five hypotheses, our data showed (a) some difference between GP and HP studies (p-value = 0.012) and (b) an association in extreme comparisons (BMI> or =32.5, 35.0, 37.5, 40.0 kg/m(2) versus BMI<25 kg/m(2)) yielding ORs of 1.16, 1.18, 1.22, or 1.27 (p-values 0.001 to 0.003), which was also underscored by significantly increased CC-genotype frequencies across BMI categories (10.4% to 12.5%, p-value for trend = 0.0002). We did not find evidence for differential ORs (c) among studies with higher than average obesity prevalence compared to lower, (d) among studies with BMI assessment after the year 2000 compared to those before, or (e) among studies from older populations compared to younger. Analysis of non-Caucasian adults (n = 4889) or children (n = 3243) yielded ORs of 1.01 (p-value = 0.94) or 1.15 (p-value = 0.22), respectively. There was no evidence for overall association of the rs7566605 polymorphism with obesity. Our data suggested an association with extreme degrees of obesity, and consequently heterogeneous effects from different study designs may mask an underlying association when unaccounted for. The importance of study design might be under-recognized in gene discovery and association replication so far.
Resumo:
O planejamento do setor agrícola tem como objeti vo básico a integração da agricultura com os demais setores, de modo a permitir uma visão global da economia, facilitar a sele ção de alternativas de prioridades e maximizar a rentabilidade sócio-econômica dos recursos à disposição do setor. A conscientização, cada vez mais crescente, da ne cessidade de adoção do planejamento como técnica que auxilia o atingimento dos objetivos de desenvolvimento nacional é enfoca do no Capítulo I. A partir de 1939; ocorrem várias tentativas de institucionalização do planejamento global no Brasil. Três fa ses são caracterizadas: a do planejamento "Ocasional", a do "Empírico" e a do "Científico". Estas tentativas sao analisa das no Capítulo 11. Os aspectos de conceituação e de princípios do planejamento setorial, num sentido amplo, e des do planejamento setorial agrícola, inclusive guras e etapas são abordados no Capítulo 111. as peculiarid~ os níveis, fi No Capítulo IV são tratados os aspectos de insti tucionalização do planejamento agrícola a nível federal, no p~ ríodo de 1960 a 1974, em três fases distintas: a "ComissionaI" (1960/66), a "Escritorial"(1967/70) e a "Secretarial" (1971/74). No Capítulo V são abordadas as políticas públicas comumente ad~ tadas, enfatizando-se com maior detalhe a política de preços mínimos, por ser a mais contínua do período. Finalmente, no Capítulo VI, são apresentadas as conclus6es, onde se mostra que alguns resultados positivos têm sido alcançados, embora existam, ainda,pontos débeis a serem atacados, tendo em vista a consolidação de uma forte organização para o planejqmento.
Resumo:
Esta monografia teve a intenção de buscar as razoes pelas quais nem as reformas nem as revoltas e, muito menos, a moder nização conseguem implementar a sua racionalidade tecnicà. Procurou mostrar como essa pretensa racionalidade aparentemente ignora - ou despreza - a rede das relações entre o saber e o poder e, atraves de um estudo de caso, procurou mostrar ainda a superficialidade do discurso modernizante e a falicia da modernização administrativa como vetor de desenvolvimento. Nesse sentido, reconstitui a genealogia d~s relaç~es de força, da estrategia e da titica reformista, utilizando com alguns "riscos" a genealogia do poder de Michel Foucault na ani l1se do discurso desenvolvimentista - modernizante, onde ficou evidenciada a burocratização do saber. Mostra, tambem, como a institucionalização dos .sistemas de administração geral e de planejamento na Administração Pública brasileira teve a pretensao de acelerar o da sociedade disciplinar. fortalecimento Pinalmente, deixa assinalado que o processo de burocratizaçãolevou o saber seculo xx a viver realim~ntando-se num discurso tautológico em detrimento da produção de saber que possibilitasse espaços de ruptura. Exemplifica, mostrando a teoria da modernização aliou um certo tipo de saber a específico campo de exercício de poder.
Resumo:
O objeto do presente estudo é a descrição e análise dos projetos de desenvolvimento de comunidade implantados em São Luís do Maranhão, pela Secretaria de Educação e Ação Comunitária, nos períodos 1971-74 (Projeto Euterpe) e 1976-78 (Proj eto Desafio), no que se refere à participação das populações carentes da periferia de são Luís na ação educativa dos referidos projetos.